In this study, we evaluated the PD‐L1 (22C3) expression in tissue samples obtained from breast cancer patients with pulmonary metastasis and determined the impact of PD‐L1‐expressing AMs on the PD‐L1 status, measured as CPS. This evidence concerns the gene CD274 and breast cancer.